STUDY00015328: Sepsis Endotypes

ClinicalTrials.gov ID: NCT03146546

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03146546. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 13, 2026, 11:53 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Diagnostic and Prognostic Biomarkers to Elucidate Sepsis Endotypes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Determine the utility of biomarkers measured in blood and body fluid (stool, saliva, tracheal aspirate) when combined with clinical data, for predicting sepsis phenotypes that are associated with poor clinical outcomes. We hypothesize that resistin is a biomarker which provides critical prognostic information when used in conjunction with standard clinical data, in patients with sepsis and septic shock.

Study identification

NCT ID: NCT03146546
Recruitment status: Enrolling by invitation
Study type: Observational
Phase: Not listed
Lead sponsor: Milton S. Hershey Medical Center; Other
Enrollment: 200 participants

Conditions and interventions

Conditions

Sepsis

Interventions

Not listed

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 6, 2020 (Actual)
Primary completion: Jun 30, 2028 (Estimated)
Completion: Jun 30, 2028 (Estimated)
Last update posted: Sep 17, 2026

2020 – 2028

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Milton S. Hershey Medical Center	Hershey	Pennsylvania	17033	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03146546, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 17, 2026 · Synced Nov 13, 2026